Drug Shortage Report for CLAVULIN 250 F ORAL SUS

Last updated on 2024-02-14 History
Report ID 175255
Drug Identification Number 01916874
Brand name CLAVULIN 250 F ORAL SUS
Common or Proper name amoxicillin / clavulanate potassium for oral suspension
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) CLAVULANIC ACID AMOXICILLIN
Strength(s) 62.5MG 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100ML
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-11-14
Estimated end date 2023-03-31
Actual end date 2023-03-15
Shortage status Resolved
Updated date 2024-02-14
Company comments Inventory on allocation to support demand. For emergency supply, contact GSK Customer Service 1-800-387-7374.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2024-02-14 English Compare
v14 2023-03-16 English Compare
v13 2023-03-15 French Compare
v12 2023-03-15 English Compare
v11 2023-02-08 French Compare
v10 2023-02-08 English Compare
v9 2023-01-11 French Compare
v8 2023-01-11 English Compare
v7 2022-11-30 French Compare
v6 2022-11-30 English Compare
v5 2022-11-18 English Compare
v4 2022-11-18 English Compare
v3 2022-11-18 English Compare
v2 2022-11-18 French Compare
v1 2022-11-18 English Compare

Showing 1 to 15 of 15